EGFR Wild-Type Sarcomatoid Carcinoma as Acquired Resistance to Tarlatamab in Small Cell-Transformed EGFR-Mutated Lung Adenocarcinoma: A Case Report.
- DOI
- 10.1016/j.jtocrr.2026.101018
- Published
- 2026 Aug
- Container
- JTO clinical and research reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2026.101018,
title = {EGFR Wild-Type Sarcomatoid Carcinoma as Acquired Resistance to Tarlatamab in Small Cell-Transformed EGFR-Mutated Lung Adenocarcinoma: A Case Report.},
author = {Kunimasa K and Honma K and Tamiya M and Inoue T and Mamesaya N and Matsumoto K and Fukumoto Y and Minami S and Harima T and Nishino K},
year = {2026},
journal = {JTO clinical and research reports},
doi = {10.1016/j.jtocrr.2026.101018},
url = {https://doi.org/10.1016/j.jtocrr.2026.101018}
}RIS
TY - JOUR TI - EGFR Wild-Type Sarcomatoid Carcinoma as Acquired Resistance to Tarlatamab in Small Cell-Transformed EGFR-Mutated Lung Adenocarcinoma: A Case Report. AU - Kunimasa K AU - Honma K AU - Tamiya M AU - Inoue T AU - Mamesaya N AU - Matsumoto K AU - Fukumoto Y AU - Minami S AU - Harima T AU - Nishino K PY - 2026 JO - JTO clinical and research reports DO - 10.1016/j.jtocrr.2026.101018 UR - https://doi.org/10.1016/j.jtocrr.2026.101018 ER -
APA
K, K., K, H., M, T., T, I., N, M., K, M., Y, F., S, M., T, H., & K, N. (2026). EGFR Wild-Type Sarcomatoid Carcinoma as Acquired Resistance to Tarlatamab in Small Cell-Transformed EGFR-Mutated Lung Adenocarcinoma: A Case Report.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2026.101018
Source records
- pubmed · retrieved 2026-09-25T22:18:31.509Z